Phase I study of everolimus (RAD001) and AMG 479 in patients (pts) with advanced solid tumors and colorectal cancer (CRC).
M. R. Khawaja
No relevant relationships to disclose
A. Younger
No relevant relationships to disclose
J. M. Funke
No relevant relationships to disclose
M. J. Waddell
No relevant relationships to disclose
D. R. Jones
No relevant relationships to disclose
K. Pollok
No relevant relationships to disclose
N. K. Prasad
No relevant relationships to disclose
W. Berry
No relevant relationships to disclose
G. Sandusky
No relevant relationships to disclose
E. G. Chiorean
Research Funding - Novartis